209 related articles for article (PubMed ID: 34086081)
1. Gabra2 is a genetic modifier of Dravet syndrome in mice.
Hawkins NA; Nomura T; Duarte S; Barse L; Williams RW; Homanics GE; Mulligan MK; Contractor A; Kearney JA
Mamm Genome; 2021 Oct; 32(5):350-363. PubMed ID: 34086081
[TBL] [Abstract][Full Text] [Related]
2. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
3. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.
Kearney JA; Copeland-Hardin LD; Duarte S; Zachwieja NA; Eckart-Frank IK; Hawkins NA
Mamm Genome; 2022 Dec; 33(4):565-574. PubMed ID: 35606653
[TBL] [Abstract][Full Text] [Related]
5. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.
Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA
Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335
[TBL] [Abstract][Full Text] [Related]
6. Potentiating α
Nomura T; Hawkins NA; Kearney JA; George AL; Contractor A
J Physiol; 2019 Aug; 597(16):4293-4307. PubMed ID: 31045243
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in a mouse model of Dravet syndrome.
Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
[TBL] [Abstract][Full Text] [Related]
8. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.
Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
Epilepsia; 2017 Aug; 58(8):e111-e115. PubMed ID: 28556246
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
[TBL] [Abstract][Full Text] [Related]
10. Adolescent behavioral abnormalities in a Scn1a
Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.
Anderson LL; Doohan PT; Hawkins NA; Bahceci D; Garai S; Thakur GA; Kearney JA; Arnold JC
Neuropharmacology; 2022 Mar; 205():108897. PubMed ID: 34822817
[TBL] [Abstract][Full Text] [Related]
12. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?
Scheffer IE; Zhang YH; Jansen FE; Dibbens L
Brain Dev; 2009 May; 31(5):394-400. PubMed ID: 19203856
[TBL] [Abstract][Full Text] [Related]
13. Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse.
Yu W; Hill SF; Xenakis JG; Pardo-Manuel de Villena F; Wagnon JL; Meisler MH
Epilepsia; 2020 Dec; 61(12):2847-2856. PubMed ID: 33140451
[TBL] [Abstract][Full Text] [Related]
14. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.
Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G
Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317
[TBL] [Abstract][Full Text] [Related]
15. Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome.
Hammer MF; Ishii A; Johnstone L; Tchourbanov A; Lau B; Sprissler R; Hallmark B; Zhang M; Zhou J; Watkins J; Hirose S
PLoS One; 2017; 12(7):e0180485. PubMed ID: 28686619
[TBL] [Abstract][Full Text] [Related]
16. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
17. A mutation in GABRB3 associated with Dravet syndrome.
Le SV; Le PHT; Le TKV; Kieu Huynh TT; Hang Do TT
Am J Med Genet A; 2017 Aug; 173(8):2126-2131. PubMed ID: 28544625
[TBL] [Abstract][Full Text] [Related]
18. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a
Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M
Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826
[TBL] [Abstract][Full Text] [Related]
19. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
[TBL] [Abstract][Full Text] [Related]
20. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
